National survey estimates prevalence of type 2 diabetes among adolescents

May 01, 2006

An estimated 39,000 U.S. adolescents may have type 2 diabetes and more than 2.5 million may have impaired fasting glucose levels, which could lead to diabetes and other health problems, according to a study in the May issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

About 18.2 million U.S. citizens have diabetes, including 210,000 individuals younger than age 20 years, according to background information in the article. Type 2 diabetes, which occurs when the body cannot use the insulin that it manufactures to break down glucose in the body, is considered an emerging problem among this age group. Studies also indicate that impaired glucose tolerance, a blood glucose level that is higher than normal but not high enough for a diagnosis of diabetes, is common among young people who are overweight and can lead to the development of diabetes.

Glen E. Duncan, Ph.D., R.C.E.P.S.M., University of Washington, Seattle, used data from a national survey of the U.S. population to determine the prevalence of diabetes and impaired fasting glucose levels (which measure blood sugar after an eight-hour fast to detect impaired glucose tolerance) among U.S. adolescents. A total of 4,370 participants aged 12 to 19 (mean age 15.4) years were asked whether they had ever been told by a physician that they had diabetes. A subsample of 1,496 adolescents who responded "no" had their glucose levels testing after fasting overnight.

Of the 4,370 original participants, 18 or 0.5 percent had diabetes; of those, about 71 percent had type 1 diabetes and 29 percent had type 2 diabetes. About 11 percent, or 178, of the subsample without diabetes had impaired fasting glucose levels. When considered as a sample of the entire population of U.S. adolescents, these numbers are equivalent to 134,071 individuals age 12 to 19 years with diabetes, 39,005 with type 2 diabetes and 2,769,736 with impaired fasting glucose levels.

"The prevalence of type 2 diabetes and impaired fasting glucose levels is substantial among U.S. adolescents," Dr. Duncan concludes.

"These estimates have important implications for public health because of the high rate of conversion from impaired fasting glucose level to type 2 diabetes in adults and the increased risk of cardiovascular disease in individuals with type 2 diabetes."
(Arch Pediatr Adolesc Med. 2006;160:523-528. Available pre-embargo to the media at

Editor's Note: This study was funded by a career development award from the National Institutes of Health.

Editorial: Testing, Intervention Required for High-Risk Teens

More frequent blood glucose and lipid testing may be necessary in certain adolescents to detect and prevent the development of diabetes and its cardiovascular complications, writes Arlan L. Rosenbloom, M.D., Children's Medical Services Center, Gainesville, Fla., in an accompanying editorial.

Those children who are overweight or at risk for being overweight "are going to require the kind of monitoring for cardiovascular risk factors that has been considered standard of care for older adults," Dr. Rosenbloom writes. "The costs of this monitoring are insignificant in comparison to the potential for prevention of early cardiovascular disease, but only if there are individual and community resources to effect lifestyle change, and if necessary, maintain compliance with medications" for risk factors such as high blood pressure and high cholesterol.

"It is to be hoped that the recognition of the public health time bomb reflected in the report by Dr. Duncan will lead to a pervasive societal effort to prevent obesity, a daunting task of such magnitude that enormous community and governmental commitments will be required," Dr. Rosenbloom concludes.

(Arch Pediatr Adolesc Med. 2006;160:550-552. Available pre-embargo to the media at

To contact editorialist Arlan L. Rosenbloom, M.D., call April Frawley Birdwell at 352-273-5817.

The JAMA Network Journals

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to